Personalized blood-thinner therapy after heart stenting
Part of Heart & circulation clinical trials.
This study tests whether tailoring blood-thinner medication based on a cheek swab can improve recovery after having a heart stent placed. Participants will be randomly assigned to one of two blood thinners, and their treatment will be adjusted based on genetic testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years old
- Have had a heart stent placed (percutaneous coronary intervention, or PCI)
- Be able to take both ticagrelor and clopidogrel (the study drugs)
- Be able to provide a cheek swab sample
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new High Risk Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.